CSFB launches $75m High Medical IPO

Premarketing got underway today (Wednesday) for the $75m IPO of Swiss medical devices manufacturer High Medical Technologies.

  • 09 Mar 2001
Email a colleague
Request a PDF
The company, which specialises in equipment for urology and orthopaedics departments, will list on the SWX New Market. Credit Suisse First Boston is sole bookrunner for the deal.

The company is planning to sell 390m shares in the base offering and 59m in the greenshoe. The total offering represents 53% of the company. The price range for the deal will be announced on March 26.

Of the issue, about half will be capital increase and half will be secondary. "The company is going to use the proceeds to finance internal growth, enter further collaboration arrangements and commission scientific and clinical surveys," said a banker close to the deal.

Bank Sarasin, Lombard Odier and Kantonalbank are co-managers.

  • 09 Mar 2001

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 13 Mar 2017
1 JPMorgan 94,925.33 384 8.39%
2 Citi 87,531.58 331 7.74%
3 Bank of America Merrill Lynch 84,341.49 288 7.46%
4 Barclays 75,288.19 241 6.66%
5 Goldman Sachs 68,504.71 208 6.06%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 May 2017
1 Deutsche Bank 19,381.65 47 8.82%
2 Bank of America Merrill Lynch 18,968.25 36 8.63%
3 HSBC 18,103.95 50 8.24%
4 BNP Paribas 8,911.57 55 4.05%
5 SG Corporate & Investment Banking 8,885.00 54 4.04%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 May 2017
1 JPMorgan 8,369.56 33 8.53%
2 UBS 8,282.28 33 8.44%
3 Citi 6,605.58 44 6.74%
4 Goldman Sachs 6,444.85 31 6.57%
5 Bank of America Merrill Lynch 6,215.31 24 6.34%